Voglimit 0.3 Tablet
Marketer
Vaks Pharma
Salt Composition
Voglibose (0.3mg)
Overview Voglimit 0.3 Tablet
Voglibose 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating elevated postprandial blood glucose. It's indicated when dietary modifications and other comparable medications prove insufficient in controlling hyperglycemia. Voglibose 0.3mg tablets should be ingested immediately before meals. Dosage and frequency are determined by your physician to optimize blood sugar control. Discontinuation should only occur under medical supervision; abrupt cessation may elevate blood glucose, potentially leading to serious complications such as renal impairment and visual disturbances. This medication forms part of a comprehensive treatment strategy encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Commonly reported side effects include flatulence, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Voglibose alone doesn't typically cause hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose tablets should be used to treat hypoglycemic episodes; sucrose is ineffective. Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Complete disclosure of all medications is crucial for safe use. Excessive alcohol consumption should be avoided due to the increased hypoglycemia risk.
Primary Ingredients of Voglimit 0.3 Tablet
The provided text is "undefined," which offers no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Voglimit 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Voglimit 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimit 0.3mg tablets should be taken on an empty stomach.
Common Side effects of Voglimit 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglimit 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimit 0.3mg tablets should be taken on an empty stomach.
How Voglimit 0.3 Tablet works:
Voglimit 0.3mg tablets manage blood sugar by blocking intestinal enzymes that digest complex carbohydrates. This action reduces postprandial hyperglycemia, preventing sharp spikes in blood glucose following meals.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Voglimit 0.3 Tablets should not be taken together.
PregnancySAFE IF PRESCRIBED
Use of Voglimit 0.3 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; however, data from human studies are currently scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglimit 0.3 Tablet without significant risk to their infant. Available human data indicates minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Voglimit 0.3 Tablet.
KidneyCAUTION
Patients with significant kidney impairment should exercise caution when using Voglimit 0.3 Tablet, as dosage modification may be necessary. A physician's consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Voglimit 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglimit 0.3 Tablet :
Omit any missed Voglimit 0.3 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Voglimit 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently